Loading your workspace…
All markets
Cyclosporiasis cases in U.S. by August 31?
Foretrace AI research
Understand the odds. Examine the reasoning.
Polymarket shows market prices. Foretrace adds AI probability estimates, opposing evidence and a price-dependent outcome or pass decision for each open market.
View a sample AI report No open markets in this event. Closed markets retain historical data.
24h volumeUnavailable
Total volume$13.1K
LiquidityUnavailable
Event end date · UTCSep 1, 2026
Price history
Market probabilityLoading price history…
Polymarket · UTC
Sampled market observations, not AI forecasts. Lines connect available observations. Legend values are current provider quotes; chart points may be older.
Outcomes & resolution rules
3 marketsThese are market-implied probabilities, not AI forecasts. A displayed quote may differ from the price available for your order.
10,000+ClosedMarket odds100%
Will there be at least 10,000 cyclosporiasis cases in the U.S. by August 31, 2026?
Yes100%Polymarket estimate
No0%Polymarket estimate
- Liquidity
- Unavailable
- Deadline · UTC
- Aug 31, 2026
- Yes bid / ask
- 99.9¢ / 100.0¢
- Trading fees
- Enabled · verify on Polymarket
Closed market · historical data
This market is closed. Its historical data remains available.
How research worksResolution rules
This market will resolve to "Yes" if there have been the specified amount or more confirmed domestically acquired cases of cyclosporiasis in humans in the territory of the United States of America since May 1, 2026, according to the CDC surveillance count by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.